Incorporated in 1994, Claris Lifesciences Limited (CLL) is an Ahmedabad based pharmaceutical company. Claris is the largest Indian sterile injectables pharmaceutical companies with a presence in 76 countries worldwide. Claris offers 113 products across multiple markets and therapeutic areas. All of these products are off-patent products.
Claris's product range across various therapeutic segments, including anaesthesia, critical care, anti-infectives, renal care, infusion therapy, enteral nutrition, parenteral nutrition and oncology.
Companies more than half of the sales come from international markets and have a strong presence in regions of Latin America, the Middle East, Africa and Central, South East and Far East Asia.
Claris's manufacturing facilities are located in Ahmedabad, India and approved by foreign regulatory authorities. The manufacturing facilities are ISO 9001-2000 and WHO GMP certified.
The promoters of the company are:
1. Mr. Arjun S. Handa
2. Sarjan Financial Private Limited
|Particulars||For the year/period ended (in Rs. million)|
|Profit After Tax (PAT)||1,303.80||1,083.95||832.72||466.93||179.30|
The objects of the issue are:
1. Setting up of a new plant comprising a small volume parenterals line, a PVC bag line, a non-PVC bag line and a fat emulsion line.
2. Setting up of a new manufacturing line for propofol and other fat emulsion products at our existing plant, Clarion IV.
3. Construction of a facility for research and development at our Clarion manufacturing facilities.
4. Prepayment of an identified term loan.
5. General corporate purposes.
»» Issue Open: Nov 24, 2010 - Dec 2, 2010
»» Issue Type: 100% Book Built Issue IPO
»» Issue Size: 12,632,477 Equity Shares of Rs. 10
»» Issue Size: Rs. 300.00 Crore
»» Face Value: Rs. 10 Per Equity Share
»» Issue Price: Rs. 228 - Rs. 235 Per Equity Share
»» Market Lot: 22 Shares
»» Minimum Order Quantity: 22 Shares
»» Listing At: BSE
Maximum Subscription Amount for Retail Investor: Rs. 2,00,000
Fitch Ratings India Private Limited has assigned an IPO Grade 3 to Claris Lifesciences Ltd IPO. This means as per Fitch, company has 'Average Fundamentals'. Fitch assigns IPO grading on a scale of 5 to 1, with Grade 5 indicating strong fundamentals and Grade 1 indicating poor fundamentals.Click here to download the Fitch IPO Grading Document for Claris Lifesciences Ltd.
Check IPO Ratings from other stock analysts.
Claris Lifesciences IPO, Claris IPO, Claris Lifesciences Ltd IPO Bidding, Claris Life IPO Allotment Status, Claris IPO drhp and Claris IPO listing.
Friday, November 26, 2010
Book Running Lead Manager to the issue has informed the Exchange that the CLARIS LIFESCIENCES LIMITED issue will close on 2 Dec, 2010 instead of the earlier closing day on 26 Nov, 2010.Post issue modification date has been revised to 3 Dec, 2010 instead of the earlier closing day on 27 Nov, 2010. Further price band has revised from 278/- to Rs. 293/- TO Rs. 228/- to Rs. 235/- per share.
|Number of Times Issue is Subscribed (BSE + NSE)|
|As on Date & Time||QIB||NII||RII||Total|
|Shares Offered / Reserved||4,572,152||1,069,192||3,207,577||8,848,921|
|Day 1 - Nov 24, 2010 17:00 IST||0.0000||0.0000||0.0700||0.0200|
|Day 2 - Nov 25, 2010 17:00 IST||0.0000||0.0100||0.2600||0.0900|
|Day 3 - Nov 26, 2010 17:00 IST||0.1500||0.1000||1.2200||0.4400|
|Day 4 - Nov 29, 2010 17:00 IST||0.1100||0.0600||1.0100||0.4200|
|Day 5 - Nov 30, 2010 17:00 IST||0.1100||0.1100||1.0200||0.4300|
|Day 6 - Dec 1, 2010 17:00 IST||0.1100||0.3000||1.0600||0.4700||0.4700|
|Day 7 - Dec 2, 2010 17:00 IST||1.3100||2.0300||1.6000||1.5000|
Vote Here ...
We provide detail comparison of stock / commodities brokers. We helped over 75,000 traders/investors to save 60% or more brokerage in last 3 years. Here is the list of popular brokers to help investors like you to find the best broker.
We can help you choosing the right broker. Contact us today...